Med News category - Thailand Medical News

Med News

Featuring latest Drug Developments and Treatment Protocols and also Updates about the Pharmaceutical Industry , both in Thailand and abroad, latest USFDA and Thai FDA approvals and also Corporate News with regards to various Pharma companies.

U.S. Medical News: America Facing A Severe Shortage Of Various Cancer Drugs Including Methotrexate, Cisplatin, And Fluorouracil. Many Americans Will Die!

U.S. Medical News - Cancer Drug Shortage Mar 17, 2023 2 years ago

U.S. Medical News: America Facing A Severe Shortage Of Various Cancer Drugs Including Methotrexate, Cisplatin, And Fluorouracil. Many Americans Will Die! U.S. Medical News: The American Society of Health-System Pharmacists (ASHP) has issued warnings that the various cancer drugs are in shortage in the country including Injectable methotrexate, cisplatin, and fluor...

Medical Warnings: BEWARE! Many Online “Patient Influencers” Are being Paid By Pharmaceutical Companies To Mislead Viewers On Prescription Drugs!

Medical Warnings - Online Influencers Mar 14, 2023 2 years ago

Medical Warnings: A new study led by researchers from University of Colorado-USA has found that many online “Patient Influencers” are being paid by pharmaceutical companies to mislead viewers on prescription drugs! In some cases, these online medical influencers are not just previous patients but also doctors, researchers and so called “experts’ and even advocacy o...

BREAKING! Study Shockingly Finds That All Whose Mothers Took The Drug Bendectin In The 1960s And 1970s Are At Risk Of Colorectal Cancer!

Colorectal Cancer - Bendectin Mar 13, 2023 2 years ago

A new study by researchers from University of Texas Health Science Center at Houston (UTHealth Houston)-USA and the School of Public Health Public Health Institute, Berkeley, California-USA have shockingly found that all whose mothers had taken the anti-nausea drug called Bendectin during pregnancy face a high risk of developing colorectal cancer! The study findings showed that prenatal e...

Pharma News: Apotex Recalls Glaucoma And Ocular Hypertension Drug Brimonidine Tartrate Ophthalmic Solution Due To Sterility Concerns

Pharma News - Apotex Mar 09, 2023 2 years ago

Pharma News: Apotex, Canada's largest generic drug maker, has announced a recall of six batches of the glaucoma and ocular hypertension drug brimonidine tartrate ophthalmic solution due to sterility concerns. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-brimonidine-tartrate-ophthalmic-solution-015-due The company is...

Pharma News: Danish Authorities Initiates Recall Of Sandoz’s Dicillin Antibiotic After Outbreak of Carbapenemase-Producing ST79 Enterobacter Hormaechei!

Pharma News - Sandoz Dicillin Feb 24, 2023 2 years ago

Pharma News: The Danish Medicines Agency has initiated a recall of Sandoz’s Dicillin antibiotics after it was discovered that the drugs were contaminated and lead to users developing an infection involving Carbapenemase-Producing ST79 Enterobacter Hormaechei. https://laegemiddelstyrelsen.dk/da/nyheder/2023/antibiotikalaegemidlet-dicillin-fra-firmaet-sandoz-tilbagekaldes/ The recall ...

Drug News: Canadian Health Authorities Reviewing Safety Of Domperidone, A Drug That Causes Lactation And Often Misused By Breastfeeding Mothers!

Drug News - Domperidone Feb 01, 2023 2 years ago

Drug News: Health Canada has reported that is reviewing the safety of the drug Domperidone, a pharmaceutical compound that blocks dopamine to the brain and is often prescribed to aid with speeding up digestion. Domperidone (Motilium) is basically a medicine that increases the movements or contractions of the stomach and bowel. Domperidone is also used to treat nausea and vomiting caused by o...

Medications And Drugs: Chronotherapy Study Finds That Usage Of The Sedative Midazolam At Night Increases Risk Of Myocardial Injury!

Medications-Drugs - Midazolam - Heart Injury - Chronotherapy Dec 07, 2022 2 years ago

Medications - Drugs: A study by researchers from the Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado-United States has found that the usage of the sedative midazolam at night increases risk of myocardial injury and heart damage! https://www.dea.gov/sites/default/files/2020-06/Benzodiazepenes-2020_1.pdf Midazolam, sold under the brand name Verse...

HIV News: New Injectable HIV PrEP That Last For Two Months Costing US$3,700 Developed For HISO Sluts And Upmarket Social Escorts!

HIV News -Long Lasting PrEP Injectables Dec 01, 2022 2 years ago

HIV News: A new injectable PrEP to combat HIV infections and can last for two months has entered the market but unfortunately the cost of the drug was deliberately aimed at HISO sluts and upmarket prostitutes as it cost about US$3,800 per dose or over US$22,000 per person per year in the United States! The new injectable PrEP called CAB-LA or cabotegravir-long acting was developed and pat...

Pharma News: University Of California Researchers Warns That NSAIDs Like Ibuprofen And Naproxen Actually Worsens Arthritis Inflammation!

Pharma News - Ibuprofen - Naproxen Nov 25, 2022 2 years ago

Pharma News: A new study lead by researchers from the Department of Radiology and Biomedical Imaging at the University of California, San Francisco- USA have found that the usage of pain relievers like Ibuprofen and Naproxen actually worsens arthritis inflammation. The study team warns that the use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are see...

Announcement: Free Amoxicillin Stocks For Hospitals And Individuals In The United States Due To Shortages, Courtesy Of Thailand Medical News

Source: Medical News - Amoxicillin - United States Nov 15, 2022 2 years ago

Due to the sudden shortage of the antibiotic Amoxicillin as oral tablets, powder suspension and especially in liquid form for intravenous use in the United States, Thailand Medical News has arranged for free disbursement of stocks to any hospitals, clinic or individuals needing it in the United States as our way of helping the American healthcare community. A post-COVID-19 surge in upper ...

First Novel Antibiotic Since 20 Years, Gepotidacin Debuts To Treat Drug Resistance Urinary Tract Infections (UTIs) Amidst Growing Incidences!

Source: Pharma News - Gepotidacin - UTIs Nov 05, 2022 2 years ago

Pharma News: Pharma giant, GSK has developed a new antibiotic called Gepotidacin that could fight tough-to-treat drug resistance urinary tract infections (UTIs). Phase 3 clinical trials proved to not only be successful but demonstrated the efficacy of the drug beyond the researchers’ expectations that the trials ended earlier than expected. https://www.gsk.com/en-gb/media/press-rele...

Cleveland Clinic And Northwestern University Study Shows That Metformin Could Be Repurposed To Treat Atrial Fibrillation. (Findings Relevant In COVID Setting)

Source: Pharma News - Metformin - Atrial Fibrillation Oct 12, 2022 2 years ago

A new study by researcher from Cleveland Clinic, Ohio-USA And Northwestern University-Illinois-USA has found that the common generic drug used to treat type 2 diabetes..metformin, can be used to treat atrial fibrillation. Atrial fibrillation (AF) is an irregular and often very rapid heart rhythm (arrhythmia) that can lead to blood clots in the heart. AF increases the risk of stroke, heart failure...

BREAKING! Children Cough Syrups And Children Paracetamol Syrup Made In India Kills 66 Children In Gambia And Sickens Hundreds More. WHO Investigating!

Source: Medical News - Pediatric Drugs Oct 06, 2022 2 years ago

A worldwide alert has been issued over children cough and cold syrups that are made in India after more than 66 children died from these contaminated products and hundreds more were sickened by them. The World Health Organization (WHO) issued the alert on Wednesday over four cough and cold syrups made by Maiden Pharmaceuticals in India, warning they are linked to the deaths of 66 children...

BREAKING! Danish Study Shows That Common NSAIDs Like Ibuprofen and Diclofenac Linked To Increased Risk Of Heart Failure In Diabetics!

Source: Medical News -NSAIDs-Heart Failure Sep 07, 2022 2 years ago

A new study by Danish researchers the Copenhagen University Hospital in Denmark has found that the usages of common NSAIDs (non-steroidal anti-inflammatory drugs) like Ibuprofen and Diclofenac by diabetics were linked to a higher risk of heart failure. The study findings were presented during the recent European Society of Cardiology annual congress or ESC Congress 2022 and will be publis...

BREAKING! U.S. FDA Study Discovers That Diabetics Taking GLP-1 Receptor Agonists Drugs Have Higher Risk Of Acute Cholecystitis And Death!

Source: Drug News - GLP-1 Receptor Agonists Drugs Sep 05, 2022 2 years ago

Drug News: Medical researchers from the U.S FDA have discovered that diabetics taking glucagon-like peptide-1 (GLP-1) receptor agonists drugs like exenatide, dulaglutide, semaglutide and lixisenatide have a higher risk of developing acute cholecystitis and even higher risk of death! The study team conducted a detailed meta-analysis from data of the of U.S FDA's reporting system for ad...

University Of Virginia Study Shows That Colchicine, A Drug To Treat Gout Also Helps Improves Survival Rates Of Heart Failure Patients!

Source: Colchicine-Heart Failure Jun 20, 2022 3 years ago

A new study by medical researchers from the University of Virginia-USA has found that the common and cheap drug that is used to treat gout- Colchicine, also helps improve the survival rates of heart failure patients. Considering that the incidences of heart failures has increased tremendously during the COVID-19 pandemic due to suspected links between the SARS-CoV-2 virus and the direct and indir...

First Published Case Report Links Usage Of Molnupiravir To Treat COVID-19 To Acute Renal Failure!

Source: Thailand Medical -Molnupiravir-COVID-19 May 08, 2022 3 years ago

Despite growing reports by many physicians around the world about a variety of adverse effects from patients who are treated with molnupiravir, the mutagenic drug that was approved by the non-credible U.S. FDA to treat COVID-19 and as usual was adopted by the stupid health authorities from various countries that emulates everything that America does, the drug is still being used by many stupid doc...

DRUG ALERT! Study Confirms That Cyproterone Acetate Widely Used In Birth Control Pills Like Diane 35 Increases Risk Of Benign Brain Tumor!

Source: Cyproterone Acetate Feb 05, 2022 3 years ago

A new study by researchers from University of Bristol-UK, National University of Singapore, University of Cambridge and Addenbrooke’s Hospital-UK and the National University Hospital-Singapore has alarmingly found that the hormone drug Cyproterone Acetate increases the risk developing benign brain tumors or meningiomas especially if used for long periods of time or in high doses. Cyproter...

Outpatients With COVID-19 Who Were On Outpatient Blood Thinners At The Time Of Diagnosis Experienced A 43 Percent Reduced Risk Of Hospitalization

Source: Blood Thinners-COVID-19 Oct 02, 2021 3 years ago

Blood Thinners-COVID-19: A new study by researchers from University of Minnesota-USA and Basel University-Switzerland has found that outpatients with COVID-19 who were on outpatient blood thinners at the time of diagnosis experienced a 43% reduced risk of hospitalization. The study focused on COVID-19 positive patients who have been taking prescribed anticoagulant class rugs including warfarin, a...

Breakthrough! University Of Alabama Study Finds That The Drug To Treat Blood Cancer-Venetoclax Could Be Repurposed To Reverse Lung Fibrosis Especially In COVID!

Source: Pulmonary Fibrosis Sep 01, 2021 3 years ago

A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials. Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...

BREAKING! Fluvoxamine- An ‘Inexpensive’ Anti-Depressant Emerging As A Leading Drug Candidate To be Repurposed To Treat COVID-19

Source: COVID-19 Drugs-Fluvoxamine Aug 14, 2021 3 years ago

COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19. Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa. Fluvoxamine, sold under the brand name Luvox among others, is an antid...

COVID-19 Drugs: Study Published In Journal Of The Heart Rhythm Society Warns That Remdesivir Can Cause Dangerously Low Heart Rate In COVID-19 Patients

Source: COVID-19 Drugs Jun 30, 2021 4 years ago

Remdesivir the controversial drug that was deemed to be ineffective in WHO’S SolidarityTrial (https://www.thailandmedical.news/news/latest-who-s-solidarity-drug-trial-shows-that-remdesivir-is-not-the-least-effective-in-treating-covid-19) but is still being approved as a drug to treat COVID-19 under EUA status in the United States by the no longer credible US FDA is now facing more backlash a...

Cancer Drugs: Pembrolizumab Approved By US FDA As First-Line Treatment For Colorectal Cancer After Positive Phase 3 Clinical Trial Results

Source: Cancer Drugs Dec 18, 2020 4 years ago

Cancer Drugs: Pembrolizumab, an immunotherapy drug has been recently approved by the U.S. FDA as a first-line treatment for patients with certain types of advanced colorectal cancer. This is the 9th FDA approval supported by Stand Up To Cancer® (SU2C) research. Individuals newly diagnosed with advanced or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (d...

Pharma News: Another Of Regeneron’s Monoclonal Antibody Drugs Garetosmab (REGN2477) Found To Cause Fatal Adverse Reactions In Clinical Trial

Source: Pharma News Nov 03, 2020 4 years ago

Pharma News: American biotech company that is linked to the corrupted Trump administration Regeneron, has another of its clinical trials halted over the weekend due to fatal adverse reactions to the monoclonal antibody drug garetosmab (REGN2477). Only about 4 days ago, another clinical trial involving another monoclonal antibody drug to treat severe COVID-19 patients was also stopped due ...

Drug News: Study Shows Gabapentin Often Prescribed To Women For Pelvic Pain Is Ineffective And Causes Lots Of Side-Effects!

Source: Drug News Sep 25, 2020 4 years ago

Drugs News: A new study by researchers from the Universities of Edinburgh, Birmingham, Oxford and Nottingham have found the drug Gabapentin that is regularly used to treat chronic pelvic pain in women has been found to be no more effective than a placebo. Chronic pelvic pain is estimated to affect 2–24% of women worldwide, and is associated with substantially reduced quality of life...

HIV Drug News: Latest Study Shows Fingolimod, A Multiple-Sclerosis Drug Blocks HIV Infections And Eradicates Latent Virus Reservoirs

Source: HIV Drug News Aug 15, 2020 4 years ago

HIV Drug News: Researchers at the George Washington University in a new study have discovered that Fingolimod, a US FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to effectively block HIV infection and reduce the latent virus reservoir. The research findings were published in the journal: PLOS Pathogens. https://journals.plos.org/plospathogens/...

TB Treatments: New Drugs Bedaquiline And Delamanid Show Early Efficacy Against Drug-Resistant Tuberculosis

Source: TB Treatments Aug 14, 2020 4 years ago

TB Treatments: New protocols involving the drugs Bedaquiline and Delamanid for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many individuals with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study. The clinical trial results, based on...

WARNING! Diabetes And Canagliflozin: Doctors Report Incident Involving Diabetic Drug Canagliflozin And Severe Statin Toxicity With Rosuvastatin

Source: Diabetes And Canagliflozin Aug 09, 2020 4 years ago

Diabetes And Canagliflozin: A serious drug interaction between canagliflozin (Invokana) and rosuvastatin (Crestor) was thought to cause liver and muscle toxicity (myotoxoicty) in a female patient in Canada, according to a new published case report. The case report was published in the medical journal: Annals of Internal Medicine as reported by Dr David Juurlink, MD, PhD, of Sunnybrook Health Sc...

Multiple Sclerosis: Novartis’s New Drug Ofatumumab Shows Ability To Prevent Multiple Sclerosis Relapses In Phase 3 Trial

Source: Multiple Sclerosis: Aug 06, 2020 4 years ago

Multiple Sclerosis: A recently completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS), the most common form of the illness, in which symptoms wax and wane. Multiple Sclerosis or MS is an autoimmune disease in which the body's immu...

Head Lice: University Of Melbourne’s New Head Lice Treatment, Xeglyze Gets US FDA Approval

Source: Head Lice Aug 04, 2020 4 years ago

Head Lice: A novel prescription head lice treatment, developed by University of Melbourne Associate Professor Dr Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in the U.S. The new treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialised by Dr. Reddy's Laboratories. Hugh Alsop, ...

Sports Medicine: Norwegian Study Reveals That Beta2-Agonists, An Asthma Drug Has Ergogenic Properties And Can Boost Sprint And Strength In Athletes

Source: Sports Medicine Aug 04, 2020 4 years ago

Sports Medicine: Researchers from Western Norway University of Applied Sciences and the Norwegian University of Sport and Physical Education have discovered that a type of asthma drug, known as ß2-agonists, can boost sprint and strength performance in athletes who don't have the respiratory condition. Their research findings have been published in the British Journal of Spo...

MEDICINE ALERT! Study Led By Penn State Shows That L-Type Calcium Channel Blockers (LCCBs) Used To Treat Hypertension May Actually Harm The Heart

Source: Medicine Alert Jul 24, 2020 4 years ago

Medicine Alert: Pennsylvania State University researchers along with scientists from La Jolla Institute for Immunology-California and Weill Cornell Medicine-Qatar, have found that in rats and human cells in vitro, LCCBs cause changes in blood vessels known as vascular remodeling that reduce blood flow and increase pressure and could potentially lead to heart failure. The study finding...

MUST READ! COVID-19 Warnings: High Blood Pressure Drug Captopril Associated With Pulmonary Adverse Reactions In COVID-19 Patients With Diabetes

Source: COVID-19 Warnings- Captopril Jul 07, 2020 5 years ago

COVID-19 Warnings: A US based study involving researchers from University of Missouri Kansas City School of Pharmacy, Kansas State University and North Carolina State University has found that the high blood pressure drug Captopril to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers (ARBs). ...

US FDA Approves First Oral Form Of Octreotide For Treatment Of Acromegaly

Source: Octreotide and Acromegaly Jun 27, 2020 5 years ago

Octreotide and Acromegaly: The American Food and drug administration has approved the first and only oral form of somatostatin analog octreotide ( tradename: Mycapssa) as a long-term maintenance therapy for individuals with acromegaly. The drug Octreotide by Chiasma pharmaceuticals is the first product approved by the FDA using Chiasma's Transient Permeability Enhancer (TPE) tec...

Multiple Sclerosis: Study Shows Most Drugs Prescribed For Treatment Of Multiple Sclerosis-Related Cognitive Impairment Do Not Work!

Source: Multiple Sclerosis Jun 18, 2020 5 years ago

Multiple Sclerosis: Medical researchers from the Kessler Foundation recently conducted a comprehensive review of pharmacologic agents used in the treatment of multiple sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals and found that most of the prescribed drugs do not work. The research findings were published in the...

Vildagliptin Just As Efficient As Metformin In Controlling Blood Sugar For Diabetics According To Indian Study

Source: Vildagliptin Versus Metformin Jun 17, 2020 5 years ago

Vildagliptin an oral anti-hyperglycemic agent that goes by the trade name Galvus showed similar protective effects as metformin on the beta-cell function, reduced insulin resistance, and blood sugar levels in newly diagnosed Asian Indians with type 2 diabetes (T2D), according to a recent study. The research trial further found that there was an improved insulin sensitivity in patients treated wi...

Pharmaceuticals: US FDA Grants Approval For Nivolumab As Treatment Drug For Esophageal Squamous Cell Carcinoma

Source: Pharmaceuticals Jun 12, 2020 5 years ago

Pharmaceuticals: The US Food and Drug Administration has approved nivolumab (OPDIVO) by Bristol-Myers Squibb for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy. Proof for efficacy was investigated in ATTRACTION-3 (NCT02569242), a multicenter, randomized (1:1), active-controlled,...

BREAKING!! Metformin: US FDA Issues Warning That Carcinogenic Contaminants Found In Several Brands Of The Diabetes Drug And Starts Recall

Source: Metformin and Diabetes May 30, 2020 5 years ago

Metformin: The US FDA has issued warnings that many brands and versions of the drug Metformin that is used by diabetics in the US and around the world have been found to be contaminated with a carcinogenic compound called N-Nitrosodimethylamine. The U.S. health regulators have started telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory te...

Janssen’s Esketamine Nasal Spray Which Is Similar To the Illegal Opioid Ketamine Gets Approved in the EU

Source: Thailand Medical News Jan 03, 2020 5 years ago

In a latest development, the European Commission (EC) has approved Johnson & Johnson subsidiary Janssen’s Spravato (esketamine) nasal spray for treatment-resistant major depressive disorder. Spravato or Esketamine is an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor and is similar in composition to illegal drug ketamine; Janssen has a risk management plan related to ...

Clinical Trials Shows That Entrectinib Performs Well In ROS1 And NTRK Gene Driven Non-Small Cell Lung Cancers

Source: Thailand Medical News Dec 14, 2019 5 years ago

Combined analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small cell lung cancers (NSCLC). Results of the trials STARTRK-1 (NCT02097810), STARTRK-2 (NCT02568267), and ALKA, show 77 percent response rate to entrectinib in 53 ...

Cinnarizine And Sodium Valproate For Pediatric Migraine Prevention

Source: Thailand Medical News Dec 11, 2019 5 years ago

A new research by pediatrics and migraine specialists from the University of Medical Sciences, Tehran show that Cinnarizine and Sodium Valproate are effective as the preventive agents of pediatric migraine in young children and teenagers. The study article entitled "Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled t...

US FDA Grants Imfinzi Priority Review For Treatment Of Extensive-Stage Small Cell Lung Cancer

Source: Thailand Medical News Dec 02, 2019 5 years ago

Pharma Conglomerate, AstraZeneca announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC). Small Cell Lung Cancer is an aggressive, fast-growing form of lung cancer that r...

US FDA Approves New Dementia Treatment Patch, SID710

Source: Thailand Medical News Nov 29, 2019 5 years ago

The US FDA (Food and Drug Administration) has approved South Korean company SK Chemicals’ patch-type Alzheimer’s drug, SID710. The drug which has already secured approval in the European Union in 2013, is the generic version of Novartis’ Exelon Patch for the treatment of dementia symptoms associated with Alzheimer’s disease. The approval marks the first time...

Acalabrutinib (Calquence) Approved By US FDA For Chronic Lymphocytic Leukemia

Source: Thailand Medical News Nov 22, 2019 5 years ago

Thailand Pharma News The US FDA has granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL).1 The Project Orbis, a collaboration between the United States, Australia, and Canada, provides a framework for concurrent submission and review of oncology pharmaceutical ap...

US FDA Approves New Antibacterial Drug Fetroja (cefiderocol) To Treat Complicated Urinary Tract Infections

Source: Thailand Medical News Nov 20, 2019 5 years ago

The US FDA (Food and Drug Administration ) has approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options. Dr John Farley, acting director of the Office of Infecti...

Novartis‘s Adakveo Approved By US FDA To Treat Sickle Cell Disease

Source: Thailand Medical News Nov 16, 2019 5 years ago

The US Food and Drug Administration approved Novartis AG's Adakveo (crizanlizumab) as new medicine that can help reduce extremely painful sickle cell disease flare-ups for patients 16 and older. The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry a list price of roughly US$82,000 to US$114,000 per year, depending on dosing. Unfortunately, sickle cell dise...

Key Drug Black Box Warnings Every Doctor Should Know

Source: Thailand Medical News Nov 10, 2019 5 years ago

The US FDA approved a record-breaking 59 novel drugs in 2018 for a range of diseases, bringing hope to scores of health sufferers around the world. This number was a more than twofold increase from a decade prior, which saw only 24 new drug approvals. And while this rise in the production and dissemination of new biological agents and products is good news for the advancement of global h...

US FDA Approves Reblozyl (Luspatercept-aamt) To Rare Blood Disorder: Beta Thalassemia

Source: Thailand Medical News Nov 09, 2019 5 years ago

The U.S. Food and Drug Administration has granted approval for Reblozyl (luspatercept-aamt) to be used for the treatment of anemia (lack of red blood cells) in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. Dr Richard Pazdur, M.D., director of the US FDA's Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in th...

Clinical Trial Shows Dupilumab (Dupixent) Helps Uncontrolled Asthma

Source: Thailand Medical News Oct 26, 2019 5 years ago

New findings from the LIBERTY ASTHMA QUEST trial show that add-on dupilumab (Dupixent) showed symptomatic benefit for patients with both early-onset and later-onset uncontrolled asthma. In trial data published in the Chest Journal, the interleukin 4 and 13 (IL-4; IL-13) targeting monoclonal antibody showed an associated reduction of severe exacerbations and improved lung function in patien...

Canagliflozin (Invokana) Approved To Treat Diabetic Kidney Disease

Source: Thailand Medical News Oct 25, 2019 5 years ago

The US FDA has approved a new indication for the SGLT2 inhibitor canagliflozin made by Janssen Pharmaceuticals to reduce the risk for end-stage renal disease, worsening of kidney function, cardiovascular death and hospitalization for heart failure among adults with type 2 diabetes and diabetic kidney disease. Type 2 diabetes is the leading cause of kidney disease in the world, and the fifth fastes...

Trikafta From Vertex Pharmaceuticals Approved By US FDA As New Treatment Drug For Cystic Fibrosis

Source: Thailand Medical News Oct 23, 2019 5 years ago

Trikafta (elexacaftor/ivacaftor/tezacaftor) from Vertex Pharmaceuticals is the first triple combination therapy to be approved by the US FDA and made available to treat patients with the most common cystic fibrosis mutation. Its list price is US$350,000 a year, same as one of the maker's earlier treatments for the genetic disease. Trikafta has been approved for patients aged 12 an...

Cheap Tranexamic Acid Meds Can Saves Millions Due To Head Injuries

Source: Thailand Medical News Oct 22, 2019 5 years ago

A study by the London School of Hygiene & Tropical Medicine has shown that Tranexamic Acid, a low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury. The findings were published in the The Lancet. The researchers say that tranexamic acid, (TXA), a drug that prevents bleeding into the brain by inhibit...

Genentech’s Flu Drug, Xofluza Obtains US FDA Approval

Source: Thailand Medical News Oct 20, 2019 5 years ago

A new flu drug by Genentech, Xofluza (baloxavir marboxil) has been granted US Food and Drug Administration (FDA) approval for a supplemental New Drug Application (NDA). The US FDA approval has been given for the indication of acute, uncomplicated influenza, or flu, in individuals aged 12 and older who have been symptomatic for no more than 48 hours and who are at high risk of developing flu-rela...

Warning: Zantac (Ranitidine) Disintegrates Into A Carcinogenic Compound

Source: Thailand Medical News Oct 14, 2019 5 years ago

New study shows that ranitidine is an unstable molecule that breaks down under different conditions into the carcinogen N-nitrosodimethylamine (NDMA). Online pharmacy Valisure is claiming that the Zantac is carcinogenic with N-nitrosodimethylamine (NDMA); that is a byproduct of the breakdown of the ranitidine molecule. The company, which performs its own testing on drugs it carries,...

Nilotinib Can Be Repurposed As A Drug For Treating Pediatric Brain Cancer

Source: Thailand Medical News Sep 23, 2019 5 years ago

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have discovered that Nilotinib (Tasigna), a drug used to treat chronic myeloid leukemia (CML) appears to be more effective at stopping a type of brain cancer called medulloblastoma in animal models than existing treatments for the deadly pediatric brain tumor. Nilotinib is a type...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM OPHTHALMOLOGY (EYE DISEASES)

LATEST ON MEDICAL INNOVATIONS /STARTUPS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

Med News

MOST READ

Interesting Reads

FROM OPHTHALMOLOGY (EYE DISEASES)

LATEST ON MEDICAL INNOVATIONS /STARTUPS